Trimethoprim-sulfamethoxazole (TMP-SMX) has traditionally been the first-line treatment for S. maltophilia infections. However, a comparative study found that levofloxacin, another antibiotic ...
The intravenous options for MRSA are generally limited to vancomycin, linezolid and TMP-SMX, although tigecycline and quinupristin–dalfopristin may have potential benefits. Ceftazidime 150 6 g 8 ...
Probability of cure of non-MRSA infection with cephalexin 0.92 0.88 0.94 33-36,42 Probability of cure of MRSA infection with cephalexin 0.6 0.4 0.8 23 Proportion of MSSA susceptible to TMP/SMX 0. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback